Updated Jul. 10, 2017 at 1:49 p.m.

Premium Lock Canada to review liver therapy developed in Durham

Published: 2017-07-07 06:07:00
Updated: 2017-07-10 13:49:21

Promethera uses ultra-cold cryopreservation of donated human liver cells, or hepatocytes, to make Heparesc. Promethera uses ultra-cold cryopreservation of donated human liver cells, or hepatocytes, to make Heparesc. Promethera photos

A cell-based therapy developed in Durham for a rare liver disease in newborns has been accepted for regulatory review in Canada....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders